Literature DB >> 10322114

Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS.

J S Felsch1, W S Lane, E G Peralta.   

Abstract

Ewing family tumors result from the effects of chromosomal translocations that fuse the Ewing sarcoma (EWS) gene to various genes encoding transcription factors. The resulting chimeric EWS fusion proteins are transcriptional activators with transforming potential that have received much study. By contrast, the cellular function of somatic EWS remains obscure. EWS belongs to a family of RNA-binding proteins thought to play role in RNA synthesis or processing. Here, we show that EWS interacts with Pyk2, a protein tyrosine kinase implicated in a variety of signal transduction processes. G-protein-coupled receptor signaling and other stimuli of Pyk2 kinase activity significantly block the interaction between EWS and Pyk2. Furthermore, as assessed by sucrose gradient centrifugation, EWS partitions with dense ribosome-containing fractions in a manner that is enhanced by signaling from the G-protein-coupled m1 muscarinic acetylcholine receptor (mAChR). We conclude that extranuclear EWS is a previously unrecognized target of G-protein-coupled receptor regulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10322114     DOI: 10.1016/s0960-9822(99)80214-0

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  11 in total

1.  In vitro interaction between the N-terminus of the Ewing's sarcoma protein and the subunit of RNA polymerase II hsRPB7.

Authors:  Roumiana Todorova
Journal:  Mol Biol Rep       Date:  2008-07-08       Impact factor: 2.316

2.  EWSR1 regulates mitosis by dynamically influencing microtubule acetylation.

Authors:  Yi-Long Wang; Hui Chen; Yi-Qun Zhan; Rong-Hua Yin; Chang-Yan Li; Chang-Hui Ge; Miao Yu; Xiao-Ming Yang
Journal:  Cell Cycle       Date:  2016-06-24       Impact factor: 4.534

3.  The RASSF1A tumor suppressor restrains anaphase-promoting complex/cyclosome activity during the G1/S phase transition to promote cell cycle progression in human epithelial cells.

Authors:  Angelique W Whitehurst; Rosalyn Ram; Latha Shivakumar; Boning Gao; John D Minna; Michael A White
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

4.  Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins.

Authors:  King Pan Ng; Gary Potikyan; Rupert O V Savene; Christopher T Denny; Vladimir N Uversky; Kevin A W Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

5.  Tyrosine Phosphorylation in the C-Terminal Nuclear Localization and Retention Signal (C-NLS) of the EWS Protein.

Authors:  Ruzanna P Leemann-Zakaryan; Steffen Pahlich; Doris Grossenbacher; Heinz Gehring
Journal:  Sarcoma       Date:  2011-05-02

6.  Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family.

Authors:  Heinrich Kovar
Journal:  Sarcoma       Date:  2010-12-09

Review 7.  Structure-function based molecular relationships in Ewing's sarcoma.

Authors:  Roumiana Todorova
Journal:  Biomed Res Int       Date:  2015-01-22       Impact factor: 3.411

8.  YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model.

Authors:  Tsion Zewdu Minas; Jenny Han; Tahereh Javaheri; Sung-Hyeok Hong; Michaela Schlederer; Yasemin Saygideğer-Kont; Haydar Çelik; Kristina M Mueller; Idil Temel; Metin Özdemirli; Heinrich Kovar; Hayriye Verda Erkizan; Jeffrey Toretsky; Lukas Kenner; Richard Moriggl; Aykut Üren
Journal:  Oncotarget       Date:  2015-11-10

9.  RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains.

Authors:  Deepa Alex; Kevin A W Lee
Journal:  Nucleic Acids Res       Date:  2005-03-02       Impact factor: 16.971

Review 10.  Ewing sarcoma protein: a key player in human cancer.

Authors:  Maria Paola Paronetto
Journal:  Int J Cell Biol       Date:  2013-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.